Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2009
10/21/2009CN101560521A VA1-missing adenovirus vector for expressing small interfering RNA (siRNA) and constructing method and application thereof
10/21/2009CN101560517A Preparation process of interleukin-2 genetic engineering gastric carcinoma cell tumour vaccine
10/21/2009CN101560514A Bridge molecule 1-siRNA interference sequence and fusion expression vector thereof
10/21/2009CN101560502A Herpes virus strains for gene therapy
10/21/2009CN101560501A Recombinant adenovirus capable of selectively expressing FADD, construction method and application thereof
10/21/2009CN101560500A Cell strain LaDR5 for secreting tumor necrosis factor receptor induced antibody
10/21/2009CN101560498A Preparation method of inactivated interleukin-2 genetic engineering gastric carcinoma cells
10/21/2009CN101560497A Preparation method of inactivated interleukin-2 genetic engineering gastric carcinoma cell tumour vaccine
10/21/2009CN101560496A Dendritic cell carried by tumor stem cell antigen and subjected to tolerance screening, preparation method and application thereof, kit and vaccine comprising dendritic cell
10/21/2009CN101560266A Oil-tea camellia husk polysaccharide and application thereof
10/21/2009CN101560265A Method for preparing oil-tea camellia husk polysaccharide and purifying method
10/21/2009CN101560260A Technique for extracting polysaccharide in glossy ganoderma mycelium cell and method thereof
10/21/2009CN101560248A Attenuated enterotoxin C2 superantigen mutant protein, preparation method and application thereof
10/21/2009CN101560246A Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs
10/21/2009CN101560243A Method for separating and purifying abrin and product thereof
10/21/2009CN101560236A Method for synthesizing marine polyhydroxyl sterol (25R)-5alpha -cholest-3 beta, 5alpha, 6beta, 26-tetrol
10/21/2009CN101560232A Method for preparing improved decitabine
10/21/2009CN101560223A Phosphoryl amino acid stilbene derivative, preparing method and application thereof
10/21/2009CN101560214A 4-amino-6-phenyl-pyrrolo[2, 3-d]pyrimidine derivatives
10/21/2009CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
10/21/2009CN101560206A Intermediate of pemetrexed disodium, preparation method thereof and method for preparing pemetrexed disodium thereby
10/21/2009CN101560198A New isoandrographolidume sulfonate, pharmaceutical composition containing sulfonate, preparation method and applications thereof
10/21/2009CN101560175A Thiourea derivatives and preparation method and use thereof
10/21/2009CN101560145A Method for separating chrysophanol and physcion by silica-gel column chromatography
10/21/2009CN101559220A Controlled live tumor cell vaccine and preparation method and application thereof
10/21/2009CN101559202A Zedoary turmeric oil adhesive membrane for external application and preparation method thereof
10/21/2009CN101559199A Chinese materia medica preparation for controlling tumor and adjunct tumor radiotherapy and chemotherapy and preparation method thereof
10/21/2009CN101559191A Pure traditional Chinese medicine capsule special for gastric cancer
10/21/2009CN101559163A Prescription of pure traditional Chinese preparation for curing cerebroma and preparation method thereof
10/21/2009CN101559158A Preparation technology of traditional Chinese medicine tablet for treating thyroma
10/21/2009CN101559157A Method for fractional extraction of asparagus saponin and asparagus amylose using asparagus slag
10/21/2009CN101559140A Micelle solution for immune regulation
10/21/2009CN101559124A Compound preparation for treating liver cancer and preparation method thereof
10/21/2009CN101559119A Edible fungi composition and application thereof
10/21/2009CN101559110A Anti-tumor medicine anemonin as well as preparation method and application of composition thereof
10/21/2009CN101559094A Production technique for extracting and separating isoflavone from red clover
10/21/2009CN101559084A Anti-tumor pharmaceutical composition and preparation method thereof
10/21/2009CN101559083A Fruiting body extract of Ganoderma Lucidum with antitumor activity and preparation method
10/21/2009CN101559076A Anti-tumor-stroma metalloprotease inhibitor
10/21/2009CN101559072A Application of polycation compound in related angiogenesis diseases
10/21/2009CN101559068A Novel application of azidothymidine in treating leukaemia
10/21/2009CN101559051A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on melanoma
10/21/2009CN101559050A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on immune system
10/21/2009CN101559037A Binary solution type preparation for intravenous injection and intracerebral injection
10/21/2009CN101558875A Granule prepared by camellia chrysantha tea and preparation method thereof
10/21/2009CN101558870A Mulberry and sea backthern concentrated food
10/21/2009CN101558808A Soft capsule of camellia chrysantha tea and preparation method thereof
10/21/2009CN100552027C Gene families associated with cancers
10/21/2009CN100552016C Bifidobacterium in treatment of inflammatory disease
10/21/2009CN100551931C T cell receptor display
10/21/2009CN100551930C Peptides modulating caspase activation
10/21/2009CN100551443C Nano carbon tube infusion agent preparation method
10/21/2009CN100551440C Therapeutic ultrasonic microvesicle for tumour ultrasonic therapy and its preparing method
10/21/2009CN100551389C Medicine for treating early bone tumor
10/21/2009CN100551375C Use of 23-hydroxy betutic acid in preparing medicine for treating and preventing glioma
10/21/2009CN100551365C Method for preparing submicron particles of taxol
10/21/2009CN100551364C Medicine use of 3 (3 nitryl-4-hydroxy)phenyl acrylate in preparing medicine for controlling xanthine oxidase
10/20/2009US7605261 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/20/2009US7605246 Genes differentially expressed in breast cancer
10/20/2009US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia
10/20/2009US7605234 Immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
10/20/2009US7605233 Tumour necrosis factor binding ligands
10/20/2009US7605179 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles
10/20/2009US7605167 Use of cyclopamine in the treatment of psoriasis
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605160 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines
10/20/2009US7605155 Enzyme inhibitors from pyrazolo[1,5a]pyrimidine as enzyme inhibitors; cyclin dependent kinases (CDKs) inhibitors; cancer, inflammation and arthritis; neurodegenerative diseases such Alzheimer's; cardiovascular, viral and fungal diseases
10/20/2009US7605154 Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
10/20/2009US7605152 such as 16 alpha -fluoro-17 beta -hydroxy-4-methyl-4-aza-5 alpha -androst-1-en-3-one, used for hormone replacement therapy
10/20/2009US7605140 Endothelial growth factors; antiischemic agents; neovascularization
10/20/2009US7604931 Cripto mutant and uses thereof
10/20/2009US7604824 Sovent extraction of hemagglutinin specific for acetyl-D-galactosamine residues of O-glycosidically linked oligosaccharide of glycophorin A by homogenizing seeds with a homogenizing agent comprising phosphate-buffered saline and glycine;centrifuging and filtering to collect supernatant; antitumor agent
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2520898C Non-cross-linking pyrrolo(2,1-c)(1,4)benzodiazepines as potential antitumour agents and process thereof
10/20/2009CA2456127C Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
10/20/2009CA2446712C System for osmotic delivery of pharmaceutically active agents
10/20/2009CA2423454C Estrogen-linked platinum (ii) complexes as anticancer agents
10/20/2009CA2407371C Quinazoline derivatives for the treatment of tumours
10/20/2009CA2397591C Semi-synthetic taxanes with antitumor and antiangiogenetic activities
10/20/2009CA2376894C Pharmaceutical composition comprising a protein and an ectoine
10/20/2009CA2368993C C7 ester substituted taxanes as antitumor agents
10/20/2009CA2358951C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/20/2009CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride
10/20/2009CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/20/2009CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/15/2009WO2009126944A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
10/15/2009WO2009126926A2 Anticancer methods employing extracts of gleditsia sinensis lam
10/15/2009WO2009126923A2 Estrogenic extracts of anemarrhena asphodeloides bge from the liliaceae family and uses thereof
10/15/2009WO2009126834A2 Combination of hgf inhibitor and egf inhibitor to treat cancer
10/15/2009WO2009126805A2 Therapeutic tarageting of mmps in neutral liposomes
10/15/2009WO2009126789A2 Engineering and delivery of therapeutic compositions of freshly isolated cells
10/15/2009WO2009126764A1 Methods and use of inducing apoptosis in cancer cells
10/15/2009WO2009126726A1 Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
10/15/2009WO2009126705A2 Induction of tumor hypoxia for cancer therapy
10/15/2009WO2009126651A2 Mat ii subunit rnai and therapeutic methods using same
10/15/2009WO2009126639A1 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
10/15/2009WO2009126637A1 Antifolate compositions
10/15/2009WO2009126584A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009WO2009126551A2 Bis-aromatic anticancer agents
10/15/2009WO2009126537A1 Administration of an inhibitor of hdac and an hmt inhibitor
1 ... 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 ... 2211